NovoCure Limited (NASDAQ:NVCR) Given Consensus Rating of "Hold" by Brokerages
NovoCure Limited (NASDAQ:NVCR – Get Rating) has earned a consensus recommendation of “Hold” from the eleven analysts that are covering the stock, Marketbeat.com reports. Two analysts have rated the stock with a sell recommendation, three have given a hold recommendation and five have issued a buy recommendation on the company. The average twelve-month price objective […]